Prevalence, Pathogenesis and Management of Anemia in Inflammatory Bowel Disease: An IG-IBD Multicenter, Prospective, and Observational Study.
Gaetano BergamaschiFabiana CastiglioneRenata D'IncàMarco AstegianoWalter FriesMonica MillaCarolina CiacciFernando RizzelloSimone SaibeniRachele CiccocioppoAmbrogio OrlandoFabrizio BossaMariabeatrice PrincipiPiero VerniaChiara RicciMaria L ScribanoGiorgia BodiniDario MazzuccoGabrio BassottiGabriele RieglerAndrea BudaMatteo NeriFlavio CaprioliFabio MonicaAldo MancaErica VillaGionata FiorinoMichele ComberlatoNicola AronicoCristina Della CorteRoberta CaccaroPaolo GionchettiPaolo GiuffridaPaola IovinoMarco V LentiCaterina MengoliLucienne PellegriniAlberto PieracciniDavide RibaldoneAnna TestaCristina UbezioAnna ViolaMaurizio VecchiCatherine KlersyAntonio Di SabatinoPublished in: Inflammatory bowel diseases (2022)
In Italy, the prevalence of IBD-associated anemia is lower than previously reported. Anemia of IBD is most commonly due to iron deficiency and contributes to fatigue and poor quality of life, but remains untreated in a large proportion of patients with iron and/or vitamin deficiencies. This study is registered at clinicaltrials.gov as NCT02872376.